Published Online
on December 24, 2007

A more recent version of this article appeared on February 1, 2008

This Article Full Text (PDF) All Versions of this Article: 51/2/175    most recent HYPERTENSIONAHA.107.102376v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mueller, C. F.H. Articles by Nickenig, G. Search for Related Content PubMed PubMed Citation Articles by Mueller, C. F.H. Articles by Nickenig, G. Related Collections Clinical Studies Mechanism of atherosclerosis/growth factors ACE/Angiotension receptors Pathophysiology Risk Factors Smooth muscle proliferation and differentiation Related Article

Angiotensin II. One Driving Force Behind Atherogenesis

Cornelius F.H. Mueller^* and Georg Nickenig

From Medizinische Klinik und Poliklinik II, Innere Medizin, Universitätsklinikum Bonn, Germany

^* To whom correspondence should be addressed. E-mail: cornelius.mueller{at}ukb.uni-bonn.de.

Related Article:

Deoxycorticosterone Acetate Salt Hypertension in Apolipoprotein E^–/– Mice Results in Accelerated Atherosclerosis: The Role of Angiotensin II

Daiana Weiss and W. Robert Taylor
Hypertension 2008 51: 218-224. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				C. Schindler ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist`s perspective after publication of the results of ONTARGET Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 233 - 248. [Abstract] [PDF]